Literature DB >> 2340220

CT morphology of benign median nerve tumors. Report of three cases and a review.

T Feyerabend1, R Schmitt, U Lanz, M Warmuth-Metz.   

Abstract

Computed tomography (CT) was performed in 3 patients with benign tumors of the median nerve, histologically confirmed as neurilemmoma, fibrolipoma and hemangioma. The neurilemmoma showed a ring-shaped contrast enhancement. The fibrolipoma presented with areas of solid soft tissue and areas of fat. The hemangioma was a solid tumor with a lacunar, vascular contrast enhancement. According to our experience and to the previous literature CT gives useful information regarding the anatomic location, size, and relationship of peripheral nerve sheath tumors to surrounding structures, and may help to differentiate between various tumor types.

Entities:  

Mesh:

Year:  1990        PMID: 2340220

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  5 in total

1.  [Intraneural hemangioma of the ulnar nerve].

Authors:  C Brand; M T Pedro; M Schick; A Scheuerle; K Scheglmann; C R Wirtz; G Antoniadis
Journal:  Nervenarzt       Date:  2015-02       Impact factor: 1.214

2.  Fibrolipomatous hamartoma: MR imaging findings.

Authors:  M De Maeseneer; S Jaovisidha; L Lenchik; D Witte; M E Schweitzer; D J Sartoris; D Resnick
Journal:  Skeletal Radiol       Date:  1997-03       Impact factor: 2.199

3.  Case report 814: Fibrolipoma of the median nerve.

Authors:  H Declercq; R De Man; G Van Herck; W Tanghe; L Lateur
Journal:  Skeletal Radiol       Date:  1993-11       Impact factor: 2.199

Review 4.  The development of musculoskeletal radiology for 100 years as presented in the pages of Acta Radiologica.

Authors:  Mats Geijer; Fatih Inci; Nektarios Solidakis; Pawel Szaro; Bariq Al-Amiry
Journal:  Acta Radiol       Date:  2021-10-19       Impact factor: 1.990

5.  Fibrolipomatous hamartoma of the median nerve on CT.

Authors:  Catherine Maldjian
Journal:  Radiol Case Rep       Date:  2015-11-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.